GALIMBERTI STEFANIA

L'Imperio, V., Capitoli, G., Cazzaniga, G., Mannino, M., Bono, F., Seminati, D., et al. (2025). The routine use of a digital tool for the tumor cell fraction quantification in molecular pathology: an international validation of QuANTUM. PATHOLOGICA, 117(3), 269-277 [10.32074/1591-951X-1100]. Dettaglio

Bindi, G., Cazzaniga, G., Alberici, F., Mescia, F., Maggioni, A., Galimberti, S., et al. (2025). Rendering the invisible visible: adding a molecular dimension to pathology with spatial omics. Intervento presentato a: SpatialOMX - Mass spectrometry MALDI imaging seminar, online. Dettaglio

Risca, G., Pelucchi, S., Mariani, R., Botti, M., Capitoli, G., Di Gennaro, F., et al. (2025). Transferrin Saturation and Serum Ferritin Are Main Predictors of Liver Iron Content in Subjects With Hyperferritinemia. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY [10.1016/j.cgh.2025.02.033]. Dettaglio

Petrosino, M., Gouvêa Bogossian, E., Rebora, P., Galimberti, S., Chesnut, R., Bouzat, P., et al. (2025). Neurological Pupil Index and Intracranial Hypertension in Patients With Acute Brain Injury. JAMA NEUROLOGY, 82(2), 176-184 [10.1001/jamaneurol.2024.4189]. Dettaglio

Cazzaniga, M., Pepe, F., Rossi, E., Coltelli, L., Beano, A., Valerio, M., et al. (2025). A Phase 2, Open Label, Multicenter, Single Arm Trial Evaluating the Activity and Safety of Abemaciclib + Aromatase Inhibitors (AIs) as Second-Line Treatment After First-Line Fulvestrant in Hormone-Receptor-Positive (HR+), Human-Epidermal-Growth-Factor-Receptor-Negative (HER2-) Metastatic Breast Cancer (MBC) Patients. Final Results of HERMIONE-7 Trial. CLINICAL BREAST CANCER, 25(6), 560-565 [10.1016/j.clbc.2025.05.003]. Dettaglio